Scientific study presented at Euroanaesthesia 2023 validates new TetraGraph algorithm
The latest generation of Senzime’s TetraGraph algorithm is shown to improve the detection of EMGs in 100% of cases, helping to better plan intraoperative drug dosing and facilitating patient safety.
Uppsala, June 5, 2023. Senzime AB (publ) today announced this weekend’s scientific presentation at Euroanaesthesia 2023 in Glasgow, UK, validating the latest enhanced TetraGraph electromyographic (EMG) detection algorithm.
Euroanaesthesia 2023 is a yearly congress organized by the European Society of Anaesthesia and Intensive Care (ESAIC). The scientific poster presentation “Prospective evaluation of an enhanced electromyographic (EMG) detection algorithm” includes an evaluation of TetraGraph’s latest EMG algorithm as compared to the previous generation for sensitivity and detection accuracy. The new EMG algorithm improves detection of EMGs in 100% of cases, without introducing false-positive EMGs. Improvements in EMG detection help better plan intraoperative drug dosing and optimal antagonism, decreasing residual paralysis and facilitating patient safety.
“The data presented in this scientific presentation solidify the place of TetraGraph as the market leader in perioperative neuromuscular monitoring. TetraGraph is an outstanding, easy-to-use, reliable and sensitive monitor; it should be the clinicians’ ideal method for prevention of postoperative residual weakness and pulmonary complications,” commented Sorin J. Brull, MD FCARCSI (Hon) Professor Emeritus of Anesthesiology and Perioperative Medicine, Mayo Clinic.
TetraGraph is a quantitative neuromuscular monitor, providing accurate monitoring of neuromuscular blockade during surgery. With the gold standard EMG technology, anesthesiologists can easily and accurately assess the patient’s depth of paralysis, enabling confident decision making during all types of surgery and for any patient position.